Merdad Parsey
Chief Tech/Sci/R&D Officer at GILEAD SCIENCES, INC.
Net worth: 7 M $ as of 2024-03-30
Profile
Dr. Merdad V. Parsey is an Independent Director at Arcus Biosciences, Inc. and a Chief Medical Officer at Gilead Sciences, Inc. He is on the Board of Directors at Arcus Biosciences, Inc. and Sagimet Biosciences, Inc. Dr. Parsey was previously employed as a Senior Medical Director by Regeneron Pharmaceuticals, Inc., a Senior Director-Medical Group by Genentech, Inc., an Associate Medical Director by Merck & Co., Inc., a Director-Critical Care Medicine by New York University School of Medicine, a Member by Roche Group, and a Senior Medical Director by Sunovion Pharmaceuticals, Inc. He received his doctorate degree from the University of Maryland.
Known holdings in public companies
Company | Date | Number of shares | Valuation | Valuation date |
---|---|---|---|---|
GILEAD SCIENCES, INC.
0.01% | 2024-03-31 | 96,304 ( 0.01% ) | 7 M $ | 2024-03-30 |
2023-07-17 | 12,794 ( 0.06% ) | 69 343 $ | 2024-03-30 |
Merdad Parsey active positions
Companies | Position | Start |
---|---|---|
SAGIMET BIOSCIENCES INC. | Director/Board Member | 2010-09-29 |
GILEAD SCIENCES, INC. | Chief Tech/Sci/R&D Officer | 2019-10-31 |
ARCUS BIOSCIENCES, INC. | Director/Board Member | 2020-07-12 |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Director/Board Member | - |
Former positions of Merdad Parsey
Companies | Position | End |
---|---|---|
REGENERON PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 2003-12-31 |
New York University School of Medicine | Corporate Officer/Principal | - |
MERCK & CO., INC. | Corporate Officer/Principal | - |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Chief Tech/Sci/R&D Officer | - |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Corporate Officer/Principal | - |
Training of Merdad Parsey
University of Maryland | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 5 |
---|---|
GILEAD SCIENCES, INC. | Health Technology |
MERCK & CO., INC. | Health Technology |
REGENERON PHARMACEUTICALS, INC. | Health Technology |
SAGIMET BIOSCIENCES INC. | Health Technology |
ARCUS BIOSCIENCES, INC. | Health Technology |
Private companies | 4 |
---|---|
Genentech, Inc.
Genentech, Inc. BiotechnologyHealth Technology Genentech, Inc. develops, manufactures and markets pharmaceutical products for life-threatening medical conditions. It studies various areas including oncology, immunology, neuroscience, ophthalmic diseases, microbial pathogenesis, metabolic diseases, cardiovascular diseases, and opportunistic areas. The company was founded by Herb W. Boyer and Robert A. Swanson in 1976 and is headquartered in South San Francisco, CA. | Health Technology |
Sumitomo Pharma America, Inc.
Sumitomo Pharma America, Inc. Pharmaceuticals: MajorHealth Technology Sumitomo Pharma America, Inc. operates as a biopharmaceutical company that develops pharmaceutical products. Its products include Aptiom (eslicarbazepine acetate) tablets, Latuda (lurasidone HCl) tablets, Lunesta (eszopiclone) tablets, Xopenex (levalbuterol HCl) Inhalation Solution, Xopenex HFA (levalbuterol tartrate) Inhalation Aerosol, Brovana (arformoterol tartrate) Inhalation Solution, Omnaris (ciclesonide) Nasal Spray, Alvesco (ciclesonide) Inhalation Aerosol, and Zetonna (ciclesonide) Nasal Aerosol. The company was founded in 2010 and is headquartered in Marlborough, MA. | Health Technology |
Roche Group
Roche Group Real Estate DevelopmentFinance Roche Group manages real estate properties. The company designs, develops and constructs residential, commercial and industrial properties. It also provides property management services. The company is headquartered in Basel, Switzerland. | Finance |
Transcelerate Biopharma, Inc.
Transcelerate Biopharma, Inc. BiotechnologyHealth Technology Transcelerate Biopharma, Inc. is a non-profit consortium that collaborates with pharmaceutical and biotechnology companies to improve the delivery of new medicines. The non-profit company is based in King of Prussia, PA. The organization's mission is to identify, prioritize, design, and facilitate implementation of solutions to drive the efficient, effective, and high-quality delivery of new medicines. Transcelerate has 20 member companies and 30+ initiatives focused on improving the patient and site experience, enhancing sponsor efficiencies and drug safety, and harmonizing processes and sharing information. The company was founded by Garry Arthur Neil, and Janice Chang has been the CEO of the company since 2014. | Health Technology |
- Stock Market
- Insiders
- Merdad Parsey